Furthermore, Graham et al. revealed that the PI3K/AKT signaling in prostate cancer cells is involved in the NFKB-mediated expression and secretion of BMP2, which stimulates the formation of bone metastases through the induction of osteoblast differentiation [110]. The gene discussed is AKT1; the disease is prostate carcinoma.